CATUMAXOMAB BECOMES THE ONLY APPROVED DRUG THERAPY FOR MALIGNANT ASCITES, A RARE AND DEBILITATING COMPLICATION OF ADVANCED-STAGE CANCER UNDER A LICENSING AGREEM ...

Background Early-life inflammation has long been recognised as a key pathophysiological process in the evolution of cystic ...

Resident macrophages play diverse roles on diabetic kidney injuries by releasing cytokines/chemokines, recruiting peripheral monocytes/macrophages ... podocyte injury is an important prognostic marker ...

Inhibiting GLS1 reduced high blood pressure in the right side of the heart of PAH rats and improved various measures of heart ...

Monocyte-like macrophage (MLM) accumulation precedes colitis-associated ... Besides the temporal changes, we investigated the differences in proinflammatory markers, myeloid cell subsets and ...

In our study, we provide evidence that tissue damage in arthritis is predominantly mediated by non-classical monocytes lacking Ly6C. Of note, we also found increased levels of markers regulating ...

In this review, we discuss S100A8/A9 as mediators of biological effects in the cardiovascular system, with a special focus on atherosclerosis and cardiac dysfunction, and S100A8/A9 as markers of ...

We evaluated adenosine deaminase 2 (ADA2), a protein of unknown function released principally by monocytes and macrophages, as a novel biomarker ... minimal association with the inflammatory markers C ...

Modest increases in concentration of C-reactive protein, a circulating marker of inflammation ... Interleukin-8 (or CXCL8) is a chemokine secreted by monocyte/macrophages whose key role in the ...

Atherosclerosis cardiovascular disease (ASCVD)-related mortality is higher in patients with lupus nephritis (LN) compared ...